Provoost Jonathan
Transaction: 07/01/2026
BUY
Change
+3,688
Price
Not reported
Filing
07/15/2026
Type
BUY
Amarin Corporation plc
AMRN • Biotechnology
$13.63
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$5.68B
Growth
-15.9%
Cash Flow
2/5
Trend
Volatile
Evidence
Positive free cash flow · 0.33Manageable debt level · 0.03Healthy liquidity · 3.34Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$13.63
Change0.00%
Shares Out416.44M
Market Cap$5.68B
Enterprise Value$5.37B
52W Range12.96 - 20.90
Beta0.80
P/E-209.28
P/S31.32
P/B12.80
P/FCF364.95
EV/Sales29.61
Price$13.63
Change0.00%
Shares Out416.44M
Market Cap$5.68B
Enterprise Value$5.37B
52W Range12.96 - 20.90
Beta0.80
P/E-209.28
P/S31.32
P/B12.80
P/FCF364.95
EV/Sales29.61
EV/EBITDA-246.98
EV/FCF345.06
Earnings Yield-0.48%
FCF Yield0.27%
Dividend Yield0.00%
Gross Margin56.57%
Oper. Margin-6.53%
Profit Margin-18.16%
Debt/Eq0.03
Current Ratio3.34
Quick Ratio2.33
Revenue 5Y-15.89%
Target$2.17
Target Upside-84.08%
Target Median$2.00
Target Range1.50 - 3.00
Volume42.13K
Avg Volume77.82K
EPS Surprise-0.10
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Positive free cash flow · 0.33Manageable debt level · 0.03Healthy liquidity · 3.34Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 18 analyst votes · 2026-09-05
53/100
Neutral
Bullish
3
Hold
13
Bearish
2
Price Target
2026-07-31
Low
$1.50
Mean
$2.17
Median
$2.00
High
$3.00
Insider Transactions
Recent executive and insider activity
Provoost Jonathan
Transaction: 07/01/2026
SELL
Change
-1,264
Price
$15.94
Filing
07/15/2026
Type
SELL
Ketchum Steven B
Transaction: 07/01/2026
BUY
Change
+3,688
Price
Not reported
Filing
07/15/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Provoost Jonathan | BUY | +3,688 | Not reported | 07/01/2026 | 07/15/2026 |
| Provoost Jonathan | SELL | -1,264 | $15.94 | 07/01/2026 | 07/15/2026 |
| Ketchum Steven B | BUY | +3,688 | Not reported | 07/01/2026 | 07/15/2026 |
| Ketchum Steven B | SELL | -1,887 | $15.94 | 07/01/2026 | 07/15/2026 |
| Keenan David Paul | BUY | +3,688 | Not reported | 07/01/2026 | 07/15/2026 |
| Keenan David Paul | SELL | -1,926 | $15.94 | 07/01/2026 | 07/15/2026 |
| Fishman Peter L. | BUY | +2,447 | Not reported | 07/01/2026 | 07/15/2026 |
| Fishman Peter L. | SELL | -1,206 | $15.94 | 07/01/2026 | 07/15/2026 |
| Berg Aaron | BUY | +6,250 | Not reported | 06/26/2026 | 06/30/2026 |
| Berg Aaron | SELL | -3,197 | $16.35 | 06/26/2026 | 06/30/2026 |
| Bonfiglio Patrice Eadon | BUY | +838 | Not reported | 04/18/2026 | 04/22/2026 |
| Bonfiglio Patrice Eadon | SELL | -403 | $14.98 | 04/18/2026 | 04/22/2026 |
| O'Connor Oliver | BUY | +838 | Not reported | 04/18/2026 | 04/21/2026 |
| O'Connor Oliver | SELL | -438 | $14.98 | 04/18/2026 | 04/21/2026 |
| Horn Keith | BUY | +838 | Not reported | 04/18/2026 | 04/21/2026 |
| Horn Keith | SELL | -403 | $14.98 | 04/18/2026 | 04/21/2026 |
| Odysseas Kostas D | BUY | +838 | Not reported | 04/18/2026 | 04/21/2026 |
| Sullivan Diane E. | BUY | +838 | Not reported | 04/18/2026 | 04/21/2026 |
| Sullivan Diane E. | SELL | -403 | $14.98 | 04/18/2026 | 04/21/2026 |
| Odysseas Kostas D | SELL | -403 | $14.98 | 04/18/2026 | 04/21/2026 |